Carbapenem-Only Combination Therapy against Multi-Drug Resistant <i>Pseudomonas aeruginosa</i>: Assessment of In Vitro and In Vivo Efficacy and Mode of Action
The aim of the study was to determine the efficacy of carbapenem-only combination treatments derived from four approved drugs (meropenem, doripenem, ertapenem and imipenem) against a MDR strain of <i>P. aeruginosa</i> in a <i>Galleria mellonella</i> larvae infection model. &l...
Main Authors: | Brendan Mackay, Benjamin J. Parcell, Sally L. Shirran, Peter J. Coote |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/11/1467 |
Similar Items
-
Overview and Insights into Carbapenem Allergy
by: Yuman Lee, et al.
Published: (2019-08-01) -
Clinical efficacy of ertapenem vs. other carbapenems for the treatment of extended-spectrum-β-lactamase-producing Enterobacterales infection: A systematic review and meta-analysis
by: Po-Yu Huang, et al.
Published: (2023-06-01) -
CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
by: I. I. Shteynberg, et al.
Published: (2015-03-01) -
Prevalence of carbapenem-resistant Enterobacterales (CRE) in Saudi Arabia: A systematic review and meta-analysis
by: Ahmad A. Alshehri, et al.
Published: (2024-11-01) -
In vitro activity of biapenem and other carbapenems against Russian clinical isolates of Pseudomonas aeruginosa, Acinetobacter spp., and Enterobacterales
by: Kozlov R.S., et al.
Published: (2021-09-01)